Cargando…
Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?
Type 2 diabetes is one of the major causes of mortality with rapidly increasing prevalence. Pharmacological treatment is the first recommended approach after failure in lifestyle changes. However, a significant number of patients shows—or develops along time and disease progression—drug resistance....
Autores principales: | Pollastro, Carla, Ziviello, Carmela, Costa, Valerio, Ciccodicola, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486250/ https://www.ncbi.nlm.nih.gov/pubmed/26161088 http://dx.doi.org/10.1155/2015/415149 |
Ejemplares similares
-
Computational Analysis of Single Nucleotide Polymorphisms Associated with Altered Drug Responsiveness in Type 2 Diabetes
por: Costa, Valerio, et al.
Publicado: (2016) -
New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma
por: Costa, Valerio, et al.
Publicado: (2015) -
Tailoring therapy for heart failure: the pharmacogenomics of adrenergic receptor signaling
por: Femminella, Grazia Daniela, et al.
Publicado: (2014) -
Pharmacogenomics in type 2 diabetes management: towards personalized medicine
por: Hu, Cheng
Publicado: (2012) -
Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy?
por: Ueno, H, et al.
Publicado: (2007)